openPR Logo
Press release

Top Market Shifts Transforming the Safety Syringe Market Landscape: Key Insights

07-31-2025 11:00 AM CET | Health & Medicine

Press release from: The Business Research Company

Safety Syringe

Safety Syringe

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Is the Expected CAGR for the Safety Syringe Market Through 2025?
Over the past few years, the safety syringe market has experienced considerable growth. The market value is expected to rise from $8.95 billion in 2024 to $9.76 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. Factors such as worries about needlestick injuries, regulatory guidelines, the adoption of more safety protocols, the rising occurrence of bloodborne diseases, and an expanding healthcare infrastructure have contributed significantly to the growth observed in the historical period.

What's the Projected Size of the Global Safety Syringe Market by 2029?
Predictions indicate substantial growth in the safety syringe market within the forthcoming years. It is projected to expand to a size of $13.78 billion by 2029, displaying a compound annual growth rate (CAGR) of 9.0%. Factors that contribute to this anticipated growth during the projection period include vaccination campaigns, an increasing elderly population, a heightened concentration on preventive healthcare, a burgeoning biopharmaceutical industry, and improvements in material sciences. Key trends expected throughout the forecast period comprise swift technological advancements, priority on sustainable solutions, the inclusion of telehealth, tailor-made solutions for specialized treatments, and improved readiness for emergencies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/safety-syringe-global-market-report

Top Growth Drivers in the Safety Syringe Industry: What's Accelerating the Market?
The growth trajectory of the safety syringe market is predicted to be positively influenced by the increasing prevalence of blood-borne diseases. These infectious diseases, brought on by various microorganisms like bacteria, viruses, or parasites, are spread via blood. Proactively utilizing safety syringes can arm healthcare professionals and their patients against blood-borne disease-related risk, minimizing accidental exposures and bolstering best practice in medical procedures. As an example, the World Health Organization, a Swiss intergovernmental organization, indicated that as of April 2024, the global tally of individuals with chronic hepatitis B infection stood at approximately 254 million for the year 2022. This figure included 1.2 million new cases reported yearly. That year, hepatitis B caused around 1.1 million fatalities, mainly because of cirrhosis and hepatocellular carcinoma (primary liver cancer). Also, globally, about 50 million are living with chronic hepatitis C virus infection, with nearly 1 million new infections each year. In 2022, hepatitis C was responsible for roughly 242,000 deaths, most often due to cirrhosis and hepatocellular carcinoma (primary liver cancer). Hence, the escalating figure for blood-borne diseases serves as a significant growth stabilizer for the safety syringe market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13924&type=smp

What Trends Will Shape the Safety Syringe Market Through 2029 and Beyond?
Leading corporations in the safety syringe market are innovating with products like the glass vaccine syringe in order to secure a dominant position in the market. This medical tool, constructed from glass, is designed to inject vaccines into patients while providing a sterile and reusable medium for administering drugs. Take for example, Becton, Dickinson, and Company, a medical device enterprise based in the United States, which introduced the BD Effivax Glass Prefillable Syringe in September 2022. These unique prefilled syringes are built to enhance the safe and dependable transport of medicines, notably vaccines. Designed for precise drug delivery, they aptly handle issues of contamination and product stability during preparation and application. Modifications in design and production procedures seek to mitigate hazards linked to conventional vial models, thereby greatly improving patient safety during vaccine administration.

What Are the Main Segments in the Safety Syringe Market?
The safety syringe market covered in this report is segmented -

1) By Product: Retractable Safety Syringes, Non Retractable Safety Syringes
2) By Therapy: Insulin, Glucagon-like peptide-I (CLP-I), Tuberculosis, Growth Hormones
3) By Application: Subcutaneous, Intramuscular
4) By End-user: Hospitals, Ambulatory Surgical Centers, Long-term Care Facilities, Specialty Clinics, Other End Users

Subsegments:
1) By Retractable Safety Syringes: Automatic Retractable Safety Syringes, Manual Retractable Safety Syringes
2) By Non-Retractable Safety Syringes: Fixed Needle Safety Syringes, Shielded Needle Safety Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13924&type=smp

Which Top Companies are Driving Growth in the Safety Syringe Market?
Major companies operating in the safety syringe market report are Cardinal Health Inc., Retractable Technologies Inc., Thermo Fisher Scientific Inc., Medtronic plc, Novo Nordisk A/s, Becton, Dickinson and Company, Baxter International Inc., Boston Scientific Corporation, Medline Industries LP, Terumo Corporation, B. Braun Melsungen AG, West Pharmaceutical Services Inc., Fresenius Kabi AG, Nemera, Smiths Medical International Ltd., Nipro Medical Corporation, Henke-Sass Wolf GmbH, Revolutions Medical Inc., Sol-Millennium Inc., UltiMed Inc., Unilife Corporation, AdvaCare Pharma, Axol Bio Corporation, Vita Needle Company, Numedico Technologies Pty Ltd., Duopross Meditech Corporation, DMC Medical Ltd., Guangdong Haiou Medical Apparatus Co. Ltd., Kendall Healthcare Group Ltd.

Which Regions Will Dominate the Safety Syringe Market Through 2029?
North America was the largest region in the safety syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13924

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Market Shifts Transforming the Safety Syringe Market Landscape: Key Insights here

News-ID: 4127922 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Syringe

Evolving Market Trends In The Smart Syringe Industry: A Revolutionary Safety Syr …
The Smart Syringe Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Smart Syringe Market Size During the Forecast Period? The Smart Syringe Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Prominent Smart Syringe Market Trend for 2025: A Revolutionary Safety Syringe Fo …
What industry-specific factors are fueling the growth of the smart syringe market? An upward surge in healthcare spending is anticipated to bolster the expansion of the smart syringes market in the future. The term "healthcare expenditure" pertains to the comprehensive sum of resources, generally quantified in financial terms, which an individual, organization, or nation dedicates towards health-related services and products. The surge in healthcare expenditure is fueled by numerous factors like
Pre-Filled Syringe (Prefilled Syringe) Market Size, Forecast: Exploring the Fore …
United States, New Jersey: According to Verified Market Reports analysis, the global Pre-Filled Syringe (Prefilled Syringe) Market Size was valued at USD 7.91 Billion in 2023 and is expected to reach USD 16.32 Billion by the end of 2031 with a CAGR of 11.1% During the Forecast Period 2024-2031. The Pre-Filled Syringe (Prefilled Syringe) Market revolves around the production and distribution of syringes prefilled with a specific dosage of medication, ready
Syringe Market Size 2024 to 2031.
Market Overview and Report Coverage A syringe is a simple pump consisting of a plunger that fits tightly in a tube. The syringe market encompasses a wide range of products, including disposable and reusable syringes used for medical purposes such as administering injections or drawing blood. The future outlook for the syringe market is promising, with a projected growth rate of 6.00% during the forecasted period. This growth can be
Global Pre-Filled Syringe (Prefilled Syringe) Market 2018 Top Players are: BD, G …
The report on the global Pre-Filled Syringe (Prefilled Syringe) market offers complete data on the Pre-Filled Syringe (Prefilled Syringe) market. Components, for example, main players, analysis, size, situation of the business, SWOT analysis, and best patterns in the market are included in the report. In addition to this, the report sports numbers, tables, and charts that offer a clear viewpoint of the Pre-Filled Syringe (Prefilled Syringe) market. The top contenders
Global Pre-Filled Syringe (Prefilled Syringe) Market to Witness Robust Expansion …
This report studies the global Pre-Filled Syringe (Prefilled Syringe) market status and forecast, categorizes the global Pre-Filled Syringe (Prefilled Syringe) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. A prefilled syringe is a single-dose packet of vaccine to which a needle has been fixed by the manufacturer. Europe has